Última fecha de actualización 16/12/2003

 

CONCLUSIONES

Se presenta el manejo de treinta pacientes sometidos a CO del maxilar superior y bimaxilar en forma ambulatoria con ingreso hospitalario a las 6 AM y una estancia hospitalaria de 12 horas máximo.

Son múltiples los factores a los que les atribuimos ésta posibilidad y son manejados en el preoperatorio inmediato, transoperatorio y postoperatorio inmediato.

Estos factores son corticoterapia, antibiotico terapia, técnica de Hipotensión Inducida, posición de la cabeza durante cirugía, uso de anestésicos locales con vasoconstrictor, método de irrigación, técnicas quirúrgicas estandarizadas, uso de medicamentos antieméticos, eliminación de cerclaje intermaxilar, vendajes compresivos, encaminados todos en conjunto a disminuir el sangrado y el tiempo quirúrgico.

La principal ADF tratada fue la Clase III Esquelética con Hipoplasia maxilar superior y el principal procedimiento quirúrgico la Osteotomía Le Fort I.

No se presentaron complicaciones transoperatorias o postoperatorias que contraindicaran el manejo ambulatorio y ningún paciente requirió transfusión sanguínea.

Este manejo reduce los costos para el paciente sin ser el objetivo principal del método.

 

BIBLIOGRAFIA

  1. De Molvan Otterloo JJ, et. al: Intra and early postoperative complications of the Le Fort 1 osteotomy: A retrospective study on 410 cases. J. Craniomaxillofac. Surg. 19:217, 1991.

  2. Lanigan D, West R: Management of postoperative hemorrhage following the Le Fort I osteotomy. J. Oral and Maxillofac Surg. 42:367, 1984.

  3. Lanigan D, Hey J, West R: Major vascular complications of orthognathic surgery: Hemorrhage associate with Le Fort I osteotomies. J Oral Maxillofac Surg. 48:56 1, 1990.

  4. Bennett J: Intravenous anesthesia for oral and maxillofacial practice. Oral and Maxillofac Surgery Clinics of North America. Vol 11, No. 4:601-609, 1999.

  5. Lopatka CW: Inhalation anesthesic agents in oral and maxillofacial office practice. Oral and Maxillofac Clinics of North America. Vol 11, No. 4: 611-623, 1999.

  6. Cushing H: Tumors of the nervous acusticus. WB Saunders, Philadelphia, 1917.

  7. Eckenhoff JE, Crompton JR, Larson A et al: Assesment of the cerebral effects of deliberate hypotension by physiological measurements. Lancet 2:711, 1969.

  8. Patel H. Experience with the cerebral function during deliderate hypotension. Br J Anesth 53:639,1981.

  9. Branston NM, Ladds A, Symon L et al: Comparison of the effects of ischemia on early components of the somato sensory evoked potentials in brainstem, thalamus and cerebral cortex. J Cereb Blood Flow Metab 4:68-8 1, 1984.

  10. Stoelting RK, Viegas O, Campbell RL: Sodium Nitroprusside produced hypotension during anesthesia and operation in the head up position. Anesth Analg 56:39 1, 1977.

  11. Bernard JM, Passuti N, Pinaud M: Long term hypotensive technique with nicardipine and nitroprusside during isofluorane anesthesia for spinal surgery. Anesth Analg, 75:179, 1992.

  12. Lam AM, Gelb AW: Cardiovascular effects of isofluorane induced hypotension for cerebral surgery. Anesth Analg 62:742, 1983.

  13. Sharrock NR, Mineo R, Urquhart B: Haemodynamic effects and outcome analysis of hypotensive extradural anesthesia in controlled hypertensive patients undergoing total Hip arthroplasty. Br J. Anaesth 67:17, 1991.

  14. Dietrich GV: Platelet function and adrenoceptors during and after induced hypotension using nitroprusside. Anesthesiology. 85(6): 13 34-40, 1996.

  15. Aoki H, Inove M, Misobe T et al: Platelet function is inhibited by nitric oxide liberation during nitroglycerin induced hypotension anesthesia. Br J Anaesth 79(4): 476-8 1, 1997.

  16. Loebl Al : Cerebellar nitric oxide is increasing during isofluorane anesthesia compared to halotane anesthesia: A microdyalisis study in rats. Anesthesiology 89(3): 723-30, 1998.

  17. Hirakata H: Sevofluorane inhibits human platelet aggregation and tromboxano A2 formation, possibly by supression of ciclooxigenase activity. Anesthesiology 85(6): 1447-53, 1996.

  18. Nozuchi S , Mizobe 1, Aoki H et al: Sevofluorane does not inhibit human platelet aggregation induced by thrombin. Anesthesiology 92(1): 164-70, 2000.

  19. Dogan IV, Ovali E, Eti Z et al: The in vitro effects of isofluorane, sevofluorane and propofol on platalet aggregation. Anesth Analg 88(2): 432-6, 1999.

  20. Pavlin JE, Coliey PS, Weymuller EA et al: Propofol versus isofluorane for endoscopic sinus surgery. Am J Otolaryngol 20(2): 96-101, 1999.

  21. Moenning ilE, Bussard DA, Lapp TH, Garrison BT : Average blood loss and the risk requiring perioperative blood transfusion in 506 orthognathic surgical procedures. J Oral Maxillofac Surg 53(8): 880-3, 1995.

  22. Shaberg SJ, Kelly JF, Teriy BC et al: Blood loss and hypotensive anesthesia in oral facial corrective surgery. J Oral Surg 34 :147, 1976.

  23. Ramez SM, Klowden A: Anesthesia for orthopedic surgery. Pediatric Anesthesia by George Gregory. Third Edition. Pg 618, 1994.

  24. Schwartz 5: Hemostasis, surgical bleeding and tranfusion. in Schwartz 5 (ed): Principles of surgery, ed 5. New York, Mc Hill, 1989.

  25. Himes RS, Difazcio CA, Burney RG: Effects of lidocaine on the anesthetic requirement for nitrous oxide and halotano. Anesthesiology. 47:437, 1997.

  26. Fourcade HE, Stevens WC, Larson CP et al: The ventilatory effects of Forance, a new inhaled anesthesic. Anesthesiology. 35: 26, 1971.

  27. Stevens WC, Kingston HG: Inhalation anesthesia. In Barash PG, Cullen BF, Stoeling RK (eds): Clinical anesthesia ed 2. Philadelphia, IB Lippincott, Pg 439-65, 1992.

  28. Di Rosa M, Colignamo A, Carnoccio R et al : Multiple control of inflammation by glucocorticoids: Agents action 17: 284, 1986.

  29. Shaberg SJ, Stuller CB, Edwards SM: Effects of methylprednisolone on swelling after orthognathic surgery. J Oral Maxillofac Surg. 42:3 56, 1984.

  30. Wang J, Ho 5, Seng J: The effect of timing of dexametasona administration on its efficacy as a prophylactic antiemetic for postperative nause and vomiting. Anesth Analg. 91: 136, 2000.

  31. Cuneyt OK, mci G : Effects of single dose steriod usage on edema, ecchymosis and intraoperative bleeding in rhinoplasty. Plast. Reconstr. Surg. 104: 2213, 1999.

  32. Lustbader DP: Perioperative fluid management in Oral and Maxillofacial surgery. Oral and Maxillofacial Surgery Clinics of Noth America. Vol 11, No. 4: 625, 1999.

  33. Vongedian 5, Asokumor B, Cheng D et al: A prospective randomized double blind study of the effect intravenous fluid therapy on adverse outcomes on outpatient surgery. Anesth Analg 80: 682-86, 1995.

  34. Fridrich KL, Partnoy BE, Zeitler DL : Prospective analysis of antibiotic prophylaxis for orthognathic surgery. Int. J, Orthod. Orthognath. Surg. 9:129, 1994.

  35. Hegtvedt AK: Intraoperative and posoperative patient care. Oral and Maxillofacial Surgery Clinics of Noth America. Vol 2, No4: 857, 1990.

  36. Song D, Whitten CW, White PF et al: Antiemetic activity of propofol after sevofluorane and desfluorane anesthesia for outpatient laparoscopic cholecystectomy. Anesthesiology. 89(4): 838-43, 1998.

  37. Gant TJ, Ginsberg B, Grant AP : Double blind, randomized comparison of ondansetron and intraoperative propofol to prevent postoperative nausea and vomiting. Anesthesiology. 8 5(5): 103642, 1996.

  38. Beli W, Chawket M, Luhr H: Art and science of the Le Fort I down fracture. Int. J Adult Ortho and Orthognath surg. Vol 3, Nol: 22-52, 1998.

  39. Ruiz CA, Munóz CA, Osorio JJ : Modification of the Mandibular intraoral sagittal osteotomy. Rev. Maxilofacial Mexicana. No.1: 5-10, 2000

  40. Bell W, Gallagher DM: The versatility of genioplasty using a broad pedicle. J Oral Maxillofac Surg. 41:763. 1983.

  41. Shuchardt K: Formen des offenen fisses und ihre operativen behand- lungsmoglich keiten. K. Shuchart and M. Hammond, Fortschr Kieter- Und Gesiehts -Chir, Stuttgart, 1995, Bd. I.Thiemen.

  42. Precious DS, Splinter W, Bosco D: Induced hypotensive anesthesia for adolescent orthognathic surgery patients. J Oral Maxillofac Surg. 54(6): 680-3, 1996.

  43. Klokgether- Radke A, Neumann 5, Neumann P et al: Ondansetron, droperidol and their combination for the prevention of postoperative vomiting. In Children. Eur J Anesthesiology. 14:362, 1997.

  44. Smith RA, Dodson TB, Cohen MI: Postoperative pulse oximetry of patients in maxillofacial fixation. J Oral Maxillofac Surg. 47: 864, 1989.

  45. Sandler NA, Braun TW : Economic analysis and its application to oral and maxillofacial surgery. J Oral Maxillofac Surg. 54(5): 622-6, 1996.

    

Haga su consulta por tema